Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shree Pacetronix's share price for the quarter that ended in Mar. 2026 was ₹91.55. Shree Pacetronix's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 3.8 Mil. Therefore, Shree Pacetronix's market cap for the quarter that ended in Mar. 2026 was ₹343.3 Mil.
Shree Pacetronix's quarterly market cap
declined
from Sep. 2025 (₹805.5 Mil) to Dec. 2025 (₹697.5 Mil) and
declined
from Dec. 2025 (₹697.5 Mil) to Mar. 2026 (₹343.3 Mil).
Shree Pacetronix's annual market cap
declined
from Mar. 2024 (₹546.1 Mil) to Mar. 2025 (₹224.3 Mil) but then
increased
from Mar. 2025 (₹224.3 Mil) to Mar. 2026 (₹343.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shree Pacetronix's Enterprise Value for Today is ₹581.6 Mil.
Shree Pacetronix (BOM:527005) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Shree Pacetronix Market Cap Related Terms
Shree Pacetronix Market Cap Historical Data
* Premium members only.
The historical data trend for Shree Pacetronix's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:527005 vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Shree Pacetronix's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Pacetronix Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's Market Cap distribution charts can be found below:
* The bar in red indicates where Shree Pacetronix's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Shree Pacetronix's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Pacetronix (BOM:527005) has a Market Cap of ₹572.6 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shree Pacetronix and its competitors. According to the industry distribution chart, Shree Pacetronix ranks #777 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 89.7%.
Is Shree Pacetronix's Market Cap too high?
Shree Pacetronix's current Market Cap is ₹572.6 Mil. Based on the distribution chart, Shree Pacetronix ranks #777 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shree Pacetronix has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shree Pacetronix ranks #777 out of 866 companies for Market Cap. This places Shree Pacetronix in the lower half of its industry. The industry median Market Cap is 116.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.94, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shree Pacetronix and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Pacetronix's current Market Cap is ₹572.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Fairly Valued. The stock's GF Value™ is ₹163.30, compared to a current price of ₹152.70 — trading 6.5% below its estimated fair value. The current Market Cap is ₹572.6 Mil. Shree Pacetronix's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current Market Cap is ₹572.6 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Pacetronix (BOM:527005) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued.
The current stock price of ₹152.70 is trading 6.5% below its estimated GF Value™ of ₹163.30.
GuruFocus considers Shree Pacetronix to be Fairly Valued.
Key valuation signals for BOM:527005:
Market Cap: ₹572.6 Mil
GF Value™: ₹163.30 vs. price of ₹152.70 (6.5% below fair value)
No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
84GF Score
Get the complete analysis for BOM:527005
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:527005 has been successfully added to your 
